APAC
Mylan’s Asia-Pacific (APAC) presence includes market-leading positions in
Australia and New Zealand, as well as a growing presence in Japan, the world’s
second-largest pharmaceutical market. Mylan maintains a full complement of
capabilities in the region, from product development and manufacturing, to
marketing and distribution of both prescription and over-the-counter medicines.
Mylan Asia-Pacific businesses include: